Medical Research for Our Troops Act

This bill restores and boosts funding for medical research in the Defense Health Agency. It raises the agency’s research, development, testing, and evaluation budget from $40.395 billion to $41.577 billion—about a $1.18 billion increase—to support programs like the Congressionally Directed Medical Research Programs. The change applies retroactively to the current full‑year funding law for 2025, so agencies can act as if this funding level had been in place from the start.

It also tells the Defense Department to run these medical research programs at the same levels and in the same way laid out in the 2024 funding law’s explanatory statement, keeping prior funding amounts and research priorities intact so projects don’t get disrupted.

Key points:

• Who is affected: Service members, veterans, military families, and researchers supported by Defense Health Agency programs.
• What changes: About $1.18 billion more for defense medical research and a requirement to follow the 2024 plan for program levels and priorities, including peer‑reviewed projects.
• When: The higher funding takes effect as if it had been in place when the 2025 full‑year funding law was enacted.